TP53 and ovarian cancer: Immunofluorescence study further showed transient FOXM1 knockdown could enhance paclitaxel-mediated cell death in two ovarian cancer cell lines, SKOV-3 (deleted p53)[17] and OVCAR3 (mutant p53) [18].